Generative AI Patient Education Module for Breast Oncology
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Pulsed Electric Field Ablation for Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Effectiveness, Safety, and Tolerability of Anti-HER2 Drugs as Targeted Therapy for Egyptian Patients With ERBB2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Sequencing SG vs. T-DXd in HER2-Low/TROP2-High Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Real-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United States
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
- Status
- RECRUITING
- Phase
- PHASE2
JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
- Status
- RECRUITING
- Phase
- NA
PTEN and Organ-Specific microRNAs in Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib Alongside Standard-of-care Endocrine Treatment in Patients With HR+/HER2- Advanced Breast Cancer and Progression on Prior Endocrine-based Treatment
- Status
- RECRUITING
- Phase
- PHASE3
Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
- Status
- RECRUITING
- Phase
- PHASE4
Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers
- Status
- RECRUITING
- Phase
- NA
A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
- Status
- RECRUITING
- Phase
- PHASE2
Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu
- Status
- RECRUITING
- Phase
- PHASE2